BioNexus Gene Lab
BGLC
#10082
Rank
C$5.9 M
Marketcap
$0.33
Share price
-14.59%
Change (1 day)
-57.31%
Change (1 year)

BioNexus Gene Lab (BGLC) - Cash on Hand

Cash on Hand as of September 2024 : C$5.94 Million

According to BioNexus Gene Lab's latest financial reports the company has C$5.94 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BioNexus Gene Lab - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31C$2.87 M6.22%
2021-12-31C$2.7 M-23.85%
2020-12-31C$3.55 M216.8%
2019-12-31C$1.12 M-34.64%
2018-12-31C$1.71 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$0.39 B 6,483.38%๐Ÿ‡บ๐Ÿ‡ธ USA